Skip to main content

Table 3 Baseline characteristics of patient cohort

From: Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methods

Median age 67.0 years (range 24–84)
Gender Male 315 (73.8):female 112 (26.2)
Histology
 Adenocarcinoma 313 (73.3)
 Squamous cell carcinoma 100 (23.4)
 Undifferentiated 5 (1.2)
 High-grade dysplasia 4 (0.9)
 Neuro-endocrine 3 (0.7)
 Small cell carcinoma 1 (0.2)
 Sarcoma 1 (0.2)
Tumour location
 Oesophagus 268 (62.8)
  Upper third 14 (5.2)
  Middle third 71 (26.5)
  Lower third 183 (68.3)
 Gastro-oesophageal junction 159 (37.2)
  Siewert I 67 (42.1)
  Siewert II 42 (26.4)
  Siewert III 50 (31.4)
Stage group
 IA 10 (2.3)
 IB 17 (4.0)
 IIA 70 (16.4)
 IIB 13 (3.0)
 IIIA 97 (22.7)
 IIIB 52 (12.2)
 IIIC 76 (17.8)
 IV 92 (21.5)
Treatment
 Curative 224 (52.5)
  NACT 86 (38.4)
  dCRT 86 (38.4)
  Surgery alone 31 (13.8)
  NACRT 20 (8.9)
  EMR 1 (0.5)
 Palliative 203 (47.5)
Mortality
 Alive 132 (30.9)
 Dead 295 (69.1)